ICMR urges institutes to complete Covaxin human trial by 7 th July


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ icmr-institutes-complete-covaxin-human-trial-7-th-july
The Indian Council of Medical Research has elected 12 institutes across the country to perform clinical trials.

The ICMR envisages inaugurating the vaccine for public health use by 15 August after fulfillment of all clinical trials, as per a letter to institutions performing trials.

The Indian Council of Medical Research has elected 12 institutes across the country to perform clinical trials of the indigenous vaccine COVAXIN to curb COVID-19 infection. ICMR had instructed the chosen clinical trial sites to accelerate approvals and finish recruiting for the trails by 7 July, as per an internal letter from ICMR to the institutions.

In the letter, ICMR says that both ICMR and Bharat Biotech are working on thee progress of the vaccine and preclinical trials currently, it adds.

"This is the first indigenous vaccine being developed by India and is one of the top priority projects which is being monitored at the topmost level of the Government," the statement says. "ICMR and BBIL are jointly working for the preclinical as well as clinical development of this vaccine."

ICMR also encourages the institutions to fast track any and all approvals needed to begin the trials and to finish recruiting subjects in five days of receiving the notice.

"Kindly note that non-compliance will be viewed seriously," the letter concludes, adding that the institutions ought to "treat the project on highest priority" and "meet the given timelines without any lapse".

India's first vaccine nominee against the novel coronavirus, received an approval from the Drug Controller General of India (DCGI) for additional clinical trials of Phase I and 2 in infected people a week ago.

The vaccine is under evolution by Hyderabad-based biotechnology firm Bharat Biotech in affiliation with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV).

Tags : #ICMR #COVID-19 #COVAXIN

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026